Location: Mobile
Synced from ClinicalTrials.gov · August 07, 2026
Clinical studies recruiting near Mobile
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
Observational Study Protocol: LIVER-R Phase N/A · Research Site · AstraZeneca · NCT06252753 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line Phase 3 · USA Mitchell Cancer Institute ( Site 0014) · Merck Sharp & Dohme LLC · NCT06136559 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) Phase 3 · Infirmary Cancer Care ( Site 0001) · Merck Sharp & Dohme LLC · NCT06393374 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed Phase 3 · USA Health Strada Patient Care Center · National Cancer Institute (NCI) · NCT06172296 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine Phase 3 · AMR Mobile · Kallyope Inc. · NCT07674654 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C Phase 3 · Mobile Infirmary Medical Center · NRG Oncology · NCT05624996 Evaluating Clinical Hiatal Hernia Outcomes Using OviTex® NA · University of South Alabama Health · Tela Bio Inc · NCT07070115 PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis Phase 3 · Cardiology Associates · Duke University · NCT07232069 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma Phase 2 · USA Health Strada Patient Care Center · Children's Oncology Group · NCT06368817 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov Phase 3 · Mobile Heart Specialists PC · Amgen · NCT07037433 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011) Phase 3 · USA Health University Hospitals ( Site 0020) · Merck Sharp & Dohme LLC · NCT07044297 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS Phase 3 · Infirmary Cancer Care · Eli Lilly and Company · NCT06890598 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Phase 3 · East View Medical Research · Janssen Research & Development, LLC · NCT07499232 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT Phase 2 · USA Health Strada Patient Care Center · Children's Oncology Group · NCT04322318 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease Phase 2/Phase 3 · Mobile Infirmary Medical Center · NRG Oncology · NCT05174169 Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight Phase 3 · AMR Clinical · Eli Lilly and Company · NCT07353931 A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT05757102 A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R- Phase 2 · Infirmary Cancer Care ( Site 0157) · Merck Sharp & Dohme LLC · NCT06890884 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta Phase 3 · Local Institution - 0487 · Bristol-Myers Squibb · NCT06561386 A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Sin Phase 3 · USA Health Children's and Women's Hospital · Pfizer · NCT06866405 Caris Biorepository Research Protocol Phase N/A · University of South Alabama · Caris Science, Inc. · NCT01499394 A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed A Phase 3 · USA Health Strada Patient Care Center · Children's Oncology Group · NCT04293562 DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carbop Phase 3 · Infirmary Cancer Care · Boehringer Ingelheim · NCT07472517 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry Phase N/A · Massive Bio SYNERGY-AI site · Massive Bio, Inc. · NCT03452774 A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD) Phase 3 · University of South Alabama (USA) Physicians Group · Takeda · NCT05442567 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit Phase 3 · Mobile Heart Specialists · Novartis Pharmaceuticals · NCT07517263 Project: Every Child for Younger Patients With Cancer Phase N/A · USA Health Strada Patient Care Center · Children's Oncology Group · NCT02402244 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq Phase 3 · University of South Alabama Mitchell Cancer Institute · NRG Oncology · NCT04852887 Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee Phase 3 · Anthos Investigative Site 1041 · Anthos Therapeutics, Inc. · NCT05712200
Look up another city
Look up another condition